fbpx
April 11, 2022

Novel Drug Shows Promise as First-Line Parkinson’s Treatment Novel Drug Shows Promise as First-Line Parkinson’s Treatment

An experimental drug that combines fixed doses of extended-release (ER) formulations of existing medications can significantly reduce symptoms in patients with untreated early-stage Parkinson’s disease (PD), […]
April 11, 2022

Shift Work May Affect Working Memory and Processing Speed Shift Work May Affect Working Memory and Processing Speed

This article was originally published in German on Medscape. Shift work is associated with poor working memory and slower mental processing speed. This is the outcome […]
April 8, 2022

Novel Steroid Therapy May Counter Ataxia Telangiectasia Novel Steroid Therapy May Counter Ataxia Telangiectasia

SEATTLE — A novel therapy for ataxia telangiectasia that delivers dexamethasone sodium phosphate (DSP) through autologous red blood cells has shown promise in a phase 3 clinical trial. […]
April 8, 2022

A Faster, Cheaper Diagnostic Test for MS? A Faster, Cheaper Diagnostic Test for MS?

A test that measures kappa immunoglobulin free light chains in cerebrospinal fluid (KCSF) is a valid option for diagnosing multiple sclerosis (MS), new research suggests. Results […]
April 8, 2022

Statins Tied to Lower Risk for Parkinsonism Statins Tied to Lower Risk for Parkinsonism

Statins may protect against age-related parkinsonism, new research suggests. The observational study showed older adults taking statins had a lower risk for parkinsonism than their counterparts […]
April 8, 2022

Final CMS Aducanumab Decision Limits Coverage to Clinical Trials Final CMS Aducanumab Decision Limits Coverage to Clinical Trials

In a final decision on the funding of the controversial Alzheimer’s drug aducanumab (Aduhelm), federal officials largely stuck to their draft plan to limit Medicare payment […]
April 7, 2022

Can MRI Provide Reliable Biomarkers for Autism Spectrum Disorder? Can MRI Provide Reliable Biomarkers for Autism Spectrum Disorder?

The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways MRI provides an important […]
April 7, 2022

Blood Testing Reveals Amyloid-Lowering Effect of Alzheimer’s Meds Blood Testing Reveals Amyloid-Lowering Effect of Alzheimer’s Meds

Lowered levels of phosphorylated (P)-tau217 and glial fibrillary acidic protein (GFAP) in the blood indicate downstream treatment effects of beta amyloid (Aβ) clearance from the brain, […]
April 7, 2022

Noncognitive Measures in Presymptomatic Alzheimer’s Disease Noncognitive Measures in Presymptomatic Alzheimer’s Disease

The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways To enable early intervention, […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0